Picture [iito] Fighting Customers 650x80px
Document › Details

NFL Biosciences S.A.. (6/30/21). "Press Release: NFL Biosciences Raises €5.0M, Following Its Successful Initial Public Offering on Euronext Growth Partis [Not for United States of America, the United Kingdom, Canada, Australia or Japan]". Montpellier.

Region Region France
Organisations Organisation NFL Biosciences S.A. (Euronext Growth Paris: ALNFL)
  Organisation 2 EuroNext Growth Paris
  Group Euronext (Group)
Products Product NFL-101 (NFL Biosciences)
  Product 2 investment banking
Index term Index term NFL Biosciences–SEVERAL: investment, 202106–202107 IPO €5m at Euronext Growh Paris with 486.2k shares in France + 829.6k shares globally at €3.8/share
Persons Person Faus, Ignacio (NFL Biosciences 202106 CEO before Mologen 201808–201903 CEO before Palau Pharma)
  Person 2 Lafont, Bruno (NFL Biosciences 202106 COO + Co-Founder)

Record changed: 2021-09-21


Picture [iito] Plain Stupid Simple 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group BIO-Europe 2021 Time to Register 650x300

» top